Light Science Technologies: Margins up, Injectaclad in — and 40,000 buildings still to treat episode artwork

EPISODE · Apr 27, 2026 · 8 MIN

Light Science Technologies: Margins up, Injectaclad in — and 40,000 buildings still to treat

from Proactive - Interviews for investors · host Proactive Investors

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon joined Proactive's Stephen Gunnion to discuss a transformational year, with gross margins up 11.5%, AgTech revenues rising 18%, and 14 new electronics clients added. The standout development was the full acquisition of Injectaclad, which Deacon called "transformational" — with around 40,000 UK buildings still requiring passive fire protection remediation, the opportunity stretches 10 to 15 years ahead. Regulatory improvements at the Building Safety Regulator are expected to release a backlog of approvals in the second half of 2026. With a £6.6 million fundraise strengthening the balance sheet, the company is targeting defence, healthcare and medical in electronics, and international expansion in AgTech through reseller networks. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #LightScienceTechnologies #LST #AIMStocks #AGTech #PassiveFireProtection #InjectorCloud #UKConstruction #BuildingSafety #ElectronicsManufacturing #DefenceSector #GrowthStocks #SmallCaps #InvestorUpdate #StockMarketUK #ProactiveInvestors

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon joined Proactive's Stephen Gunnion to discuss a transformational year, with gross margins up 11.5%, AgTech revenues rising 18%, and 14 new electronics clients added. The standout development was the full acquisition of Injectaclad, which Deacon called "transformational" — with around 40,000 UK buildings still requiring passive fire protection remediation, the opportunity stretches 10 to 15 years ahead. Regulatory improvements at the Building Safety Regulator are expected to release a backlog of approvals in the second half of 2026. With a £6.6 million fundraise strengthening the balance sheet, the company is targeting defence, healthcare and medical in electronics, and international expansion in AgTech through reseller networks. For more insights like this, visit Proactive's YouTube channel, like this video, subscribe, and enable notifications so you never miss an update. #LightScienceTechnologies #LST #AIMStocks #AGTech #PassiveFireProtection #InjectorCloud #UKConstruction #BuildingSafety #ElectronicsManufacturing #DefenceSector #GrowthStocks #SmallCaps #InvestorUpdate #StockMarketUK #ProactiveInvestors

NOW PLAYING

Light Science Technologies: Margins up, Injectaclad in — and 40,000 buildings still to treat

0:00 8:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Proactive - Interviews for investors?

This episode is 8 minutes long.

When was this Proactive - Interviews for investors episode published?

This episode was published on April 27, 2026.

What is this episode about?

Light Science Technologies Holdings PLC (AIM:LST, FRA:9FD) CEO Simon Deacon joined Proactive's Stephen Gunnion to discuss a transformational year, with gross margins up 11.5%, AgTech revenues rising 18%, and 14 new electronics clients added. The...

Can I download this Proactive - Interviews for investors episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!